Bronislaw Pytowski
Overview
Explore the profile of Bronislaw Pytowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
3200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Hooper A, Butler J, Nolan D, Kranz A, Iida K, Kobayashi M, et al.
Cell Stem Cell
. 2009 Mar;
4(3):263-74.
PMID: 19265665
Myelosuppression damages the bone marrow (BM) vascular niche, but it is unclear how regeneration of bone marrow vessels contributes to engraftment of transplanted hematopoietic stem and progenitor cells (HSPCs) and...
22.
Xue Y, Religa P, Cao R, Hansen A, Lucchini F, Jones B, et al.
Proc Natl Acad Sci U S A
. 2008 Nov;
105(47):18513-8.
PMID: 19017793
The underlying mechanism by which anti-VEGF agents prolong cancer patient survival is poorly understood. We show that in a mouse tumor model, VEGF systemically impairs functions of multiple organs including...
23.
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis
Burton J, Priceman S, Sung J, Brakenhielm E, An D, Pytowski B, et al.
Cancer Res
. 2008 Oct;
68(19):7828-37.
PMID: 18829538
Lymph node involvement denotes a poor outcome for patients with prostate cancer. Our group, along with others, has shown that initial tumor cell dissemination to regional lymph nodes via lymphatics...
24.
Tammela T, Zarkada G, Wallgard E, Murtomaki A, Suchting S, Wirzenius M, et al.
Nature
. 2008 Jul;
454(7204):656-60.
PMID: 18594512
Angiogenesis, the growth of new blood vessels from pre-existing vasculature, is a key process in several pathological conditions, including tumour growth and age-related macular degeneration. Vascular endothelial growth factors (VEGFs)...
25.
Petrova T, Bono P, Holnthoner W, Chesnes J, Pytowski B, Sihto H, et al.
Cancer Cell
. 2008 Jun;
13(6):554-6.
PMID: 18538738
No abstract available.
26.
Uzarski J, Drelles M, Gibbs S, Ongstad E, Goral J, McKeown K, et al.
Am J Physiol Heart Circ Physiol
. 2008 Jan;
294(3):H1326-34.
PMID: 18203849
Lymphangiogenesis is considered a promising approach for increasing fluid drainage during secondary lymphedema. However, organization of lymphatics into functional capillaries may be dependent upon interstitial flow (IF). The present study...
27.
Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C
Graefes Arch Clin Exp Ophthalmol
. 2007 Oct;
246(1):115-9.
PMID: 17909835
Purpose: Inflammatory corneal hem- and lymphangiogenesis occurring both prior to as well as after penetrating keratoplasty significantly increase the risk for subsequent immune rejections. The purpose of this study was...
28.
Chen L, Hamrah P, Cursiefen C, Zhang Q, Pytowski B, Wayne Streilein J, et al.
Ocul Immunol Inflamm
. 2007 Jul;
15(3):275-8.
PMID: 17613841
No abstract available.
29.
Laakkonen P, Waltari M, Holopainen T, Takahashi T, Pytowski B, Steiner P, et al.
Cancer Res
. 2007 Jan;
67(2):593-9.
PMID: 17234768
Vascular endothelial growth factor receptor 3 (VEGFR-3) binds VEGF-C and VEGF-D and is essential for the development of the lymphatic vasculature. Experimental tumors that overexpress VEGFR-3 ligands induce lymphatic vessel...
30.
Goldman J, Rutkowski J, Shields J, Pasquier M, Cui Y, Schmokel H, et al.
FASEB J
. 2007 Jan;
21(4):1003-12.
PMID: 17210781
Activation of vascular endothelial growth factor (VEGF) receptor-3 (VEGFR-3) by VEGF-C initiates lymphangiogenesis by promoting lymphatic proliferation and migration. However, it is unclear whether VEGFR-3 signaling is required beyond these...